REQUEST A DEMO
Total
USD $0.00
Search more companies

Balkanpharma Razgrad AD (Bulgaria)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Balkanpharma Razgrad AD Profile Updated: September 08, 2023
Buy our report for this company USD 19.99 Most recent financial data: 2022 Available in: English Download a sample report

Balkanpharma Razgrad AD, established in 1954, is engaged in the production of pharmaceutical products. It manufactures capsules and tablets, liquid sterile and dry injections, semi-solid forms, such as creams and ointments for topical and ophthalmic application. In June 1999, local company Balkanpharma became Bulgaria's largest pharmaceuticals group after acquiring three drug makers - Balkanpharma-Razgrad, a plant in Dupnitsa, which focuses on solid dose drugs and a drug maker from Troyan that produces liquid drugs only. The total sum of the deal was USD 24 million. In December 2000, Iceland-based generic drugs maker Pharmaco (later renamed Actavis) acquired Balkanpharma Holding, gaining control of its three plants. In July 2003, the Razgrad plant closed three of its production units since they did not comply with the EU Good Manufacturing Practices (GMP). In 2008 Iceland's Actavis Group sold the antibiotics production plant Balkanpharma Razgrad to local Antibiotic Razgrad.

Headquarters
68 Aprilsko Vastanie Blvd.
Razgrad; Razgrad; Postal Code: 7200

Contact Details: Purchase the Balkanpharma Razgrad AD report to view the information.

Website: http://www.actavis.bg

Basic Information
Total Employees:
Purchase the Balkanpharma Razgrad AD report to view the information.
Outstanding Shares:
Purchase the Balkanpharma Razgrad AD report to view the information.
Registered Capital:
Purchase the Balkanpharma Razgrad AD report to view the information.
Financial Auditors:
Purchase the Balkanpharma Razgrad AD report to view the information.
Incorporation Date:
October 23, 1991
Key Executives
Purchase this report to view the information.
Executive Director and Member of the Board of Directors
Purchase this report to view the information.
Executive Director and Member of the Board of Directors
Purchase this report to view the information.
Member of the Board of Directors
Purchase this report to view the information.
Member of the Board of Directors
Purchase this report to view the information.
Member of the Board of Directors
Ownership Details
Purchase this report to view the information.
98.12%
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Balkanpharma Razgrad AD report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency BGN. Absolute financial data is included in the purchased report.
Net sales revenue
26.5%
Total operating revenue
34.68%
Net Profit (Loss) for the Period
54.53%
Total assets
10.73%
Total equity
-3.75%
Net Profit Margin
5.54%
Return on Equity (ROE)
4.36%
Quick Ratio
1.11%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?